- Home
- SANG vs FBRX Comparison
SANG vs FBRX Comparison
Compare SANG & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- FBRX
- Stock Information
- Founded
- SANG 1984
- FBRX N/A
- Country
- SANG Canada
- FBRX United States
- Employees
- SANG N/A
- FBRX N/A
- Industry
- SANG Computer Software: Programming Data Processing
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- SANG Technology
- FBRX Health Care
- Exchange
- SANG Nasdaq
- FBRX Nasdaq
- Market Cap
- SANG 168.6M
- FBRX 154.5M
- IPO Year
- SANG 2021
- FBRX N/A
- Fundamental
- Price
- SANG $4.90
- FBRX $12.22
- Analyst Decision
- SANG
- FBRX Strong Buy
- Analyst Count
- SANG 0
- FBRX 3
- Target Price
- SANG N/A
- FBRX $68.00
- AVG Volume (30 Days)
- SANG 4.8K
- FBRX 91.8K
- Earning Date
- SANG 11-10-2025
- FBRX 11-13-2025
- Dividend Yield
- SANG N/A
- FBRX N/A
- EPS Growth
- SANG N/A
- FBRX N/A
- EPS
- SANG N/A
- FBRX N/A
- Revenue
- SANG $236,692,000.00
- FBRX N/A
- Revenue This Year
- SANG N/A
- FBRX N/A
- Revenue Next Year
- SANG $5.68
- FBRX N/A
- P/E Ratio
- SANG N/A
- FBRX N/A
- Revenue Growth
- SANG N/A
- FBRX N/A
- 52 Week Low
- SANG $4.08
- FBRX $4.44
- 52 Week High
- SANG $7.99
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- SANG 45.90
- FBRX 49.52
- Support Level
- SANG $4.77
- FBRX $10.30
- Resistance Level
- SANG $5.09
- FBRX $15.01
- Average True Range (ATR)
- SANG 0.12
- FBRX 1.16
- MACD
- SANG -0.00
- FBRX -0.14
- Stochastic Oscillator
- SANG 26.92
- FBRX 46.33
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).